title: [The acute and chronic effects of bunazosin on exercise capacity estimated by the anaerobic threshold in patients with chronic congestive heart failure].
abstract: To study the effect of bunazosin on exercise capacity in patients with congestive heart failure (NYHA II-III), anaerobic thresholds (AT, VO2, ml/min/kg) were measured before (control) and after initial 1 = 2mg administration of bunazosin (acute phase; N = 14) and after two weeks of bunazosin therapy (3mg/day, 1mg t. i. d., chronic phase; N = 6). AT were determined by Wasserman's V-slope method during ergometer exercise test with a ramp loading (10 watt/min). AT increased significantly from control during both acute (14.2 +/- 2.7 to 16.9 +/- 3.6 ml/min/kg p < 0.005) and chronic (13.6 +/- 2.5 to 16.7 +/- 1.0 p < 0.05) phase. Additionally, work (watt) attained at AT increased significantly from control during both acute (33.6 +/- 19.2 to 52.6 +/- 30.2 p < 0.005) and chronic (35.8 +/- 25 to 49.3 +/- 15 p < 0.05) phase. Pressure-rate-products (PRP, x 10(2) mmHg/min) at AT increased significantly from control during the acute phase (119 +/- 35 to 240 +/- 50 p < 0.005) alone. In the chronic phase, PRP decreased significantly at the work level equal to AT during control (from 207 +/- 41 to 187 +/- 39 p < 0.05). These data suggest that bunazosin has favorable acute and chronic effects on exercise capacity in patients with congestive heart failure.
authors.affiliation: Department of Cardiology, Tokyo Women's Medical College.
authors.forename: Y
authors.initials: Y
authors.lastname: Kawagoe
authors.forename: H
authors.initials: H
authors.lastname: Kimura
authors.forename: N
authors.initials: N
authors.lastname: Kaneko
authors.forename: T
authors.initials: T
authors.lastname: Sumiyoshi
authors.forename: H
authors.initials: H
authors.lastname: Nagashima
authors.forename: S
authors.initials: S
authors.lastname: Kimata
authors.forename: S
authors.initials: S
authors.lastname: Hosoda
authors.forename: K
authors.initials: K
authors.lastname: Konno
authors.forename: N
authors.initials: N
authors.lastname: Miki
mesh_terms: D000328:Adult; D000368:Aged; D015308:Anaerobic Threshold / Q000187:drug effects*; D002908:Chronic Disease; D005080:Exercise Test; D017079:Exercise Tolerance / Q000187:drug effects*; D005260:Female; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D011799:Quinazolines / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D011799:Quinazolines; C018176:bunazosin